Skip to content

NanoViricides to provide COVID-19 drug update on September 3

September 2, 2020

NanoViricides (NYSEMKT:NNVC) will present an update on the COVID-19 drug development at the LD 500 investor conference on September 3rd at 11:20 AM EDT.

The Company has completed Chemistry, Manufacture, and Controls studies that would be required for an IND application to the FDA.

NNVC is currently conducting studies to finalize its clinical candidate.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: